Hangzhou Tigermed Consulting Co., Ltd (SHE: 300347)

Hangzhou Tigermed Consulting Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 7, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	50,998	44,807	87,567	104,196	139,718	47,335
Market Cap Growth	-26.40%	-48.83%	-15.96%	-25.42%	195.17%	121.37%
Enterprise Value	55,154	44,345	85,466	98,831	130,576	47,065
Last Close Price	63.02	54.33	102.69	124.47	157.13	61.19
PE Ratio	48.37	23.22	44.26	37.72	71.75	54.15
PS Ratio	7.76	6.07	12.36	19.99	43.77	16.89
PB Ratio	2.61	1.83	3.86	5.06	7.82	8.57
P/FCF Ratio	91.43	53.55	96.34	98.75	165.90	111.47
P/OCF Ratio	40.99	38.95	64.51	73.18	139.90	89.72
EV/Sales Ratio	7.84	6.01	12.06	18.96	40.90	16.79
EV/EBITDA Ratio	30.43	23.64	44.48	67.76	136.22	62.22
EV/EBIT Ratio	36.94	26.23	48.48	73.55	148.61	65.99
EV/FCF Ratio	92.90	53.00	94.03	93.66	155.05	110.83
Debt / Equity Ratio	0.17	0.14	0.12	0.05	0.02	0.18
Debt / EBITDA Ratio	2.24	1.68	1.34	0.64	0.32	1.35
Debt / FCF Ratio	6.85	4.00	2.99	0.92	0.39	2.40
Asset Turnover	0.23	0.26	0.28	0.24	0.24	0.47
Inventory Turnover	178.10	199.06	302.27	544.16	566.25	1740.11
Quick Ratio	1.41	2.72	2.95	4.46	10.17	1.86
Current Ratio	1.43	2.74	2.98	4.50	10.22	1.88
Return on Equity (ROE)	5.41%	9.12%	10.50%	17.64%	17.36%	22.80%
Return on Assets (ROA)	3.11%	3.70%	4.30%	3.88%	4.06%	7.55%
Return on Capital (ROIC)	3.37%	3.97%	4.69%	4.22%	4.44%	8.76%
Earnings Yield	2.07%	4.52%	2.29%	2.76%	1.25%	1.78%
FCF Yield	1.09%	1.87%	1.04%	1.01%	0.60%	0.90%
Dividend Yield	0.85%	1.05%	0.54%	0.40%	0.19%	0.45%
Payout Ratio	53.32%	29.13%	24.52%	9.89%	15.50%	31.60%
Buyback Yield / Dilution	-0.15%	0.07%	0.62%	-9.01%	-7.27%	0.63%
Total Shareholder Return	0.70%	1.11%	1.16%	-8.61%	-7.08%	1.08%

Source: S&P Capital IQ. Standard template. Financial Sources.